lactobacillus-crispatus

Technion-Israel

October 21, 2023
recurrent-urinary-tract-infections, lactobacillus-crispatus, microbiome-engineering
therapeutics

Technion-Israel # UTBye – Treating recurrent urinary tract infection using genetically modified Lactobacillus Crispatus # Recurrent Urinary Tract Infections (UTIs), predominantly affecting women, pose a significant health concern. Current treatments rely on antibiotics, leading to resistance and questionable efficacy. In response, our iGEM project explores the under-researched realm of recurrent UTI treatment. We’ve identified the microbiome’s pivotal role in maintaining urinary tract balance, highlighting Lactobacillus crispatus as a key player. ...